GO term name | NLGN1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NRXN1-α | NRXN1-β | NRXN2-α | NRXN2-β | NRXN3-α | NRXN3-β | CNTNAP1 | SHANK1 | SHANK2 | SHANK3 | DLG4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cell adhesion molecule binding | X | X | X | X | X | X | X | X | X | X | X | Â | Â | Â | Â | Â |
receptor activity | X | X | X | X | X | X | X | X | X | X | X | X | Â | Â | Â | Â |
neurexin family protein binding | X | X | X | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
neuroligin family protein binding | Â | Â | Â | Â | Â | X | X | X | X | X | X | Â | Â | Â | Â | X |
calcium channel regulator activity | Â | Â | Â | Â | Â | X | X | X | Â | X | Â | Â | Â | Â | Â | Â |
acetylcholine receptor binding | Â | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
GKAP/Homer scaffold activity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | X | X | Â |
scaffold protein binding | Â | Â | X | X | X | Â | Â | Â | Â | Â | Â | Â | X | Â | X | X |
receptor signaling complex scaffold activity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â | Â |
ionotropic glutamate receptor binding | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | X | X | X |
somatostatin receptor binding | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â | Â |
beta-1 adrenergic receptor binding | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
D1 dopamine receptor binding | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
P2Y1 nucleotide receptor binding | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |